Bio-Techne Corporation
NASDAQ: TECH0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Kim Kelderman
- Employees
- 3,100
- Headquarters
- Minneapolis, United States
- IPO year
- 1989
- Market cap
- $11.1B
- Website
- https://www.bio-techne.com
Loading TECH…
Loading profile data…Frequently asked questions about TECH
What does Bio-Techne Corporation (TECH) do?
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research, diagnostics, and bioprocessing markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Spatial Biology. The Protein Sciences segment develops and...
Where does TECH trade?
Bio-Techne Corporation (TECH) trades on the NASDAQ.
What sector is TECH in?
Bio-Techne Corporation (TECH) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Bio-Techne Corporation?
Kim Kelderman is the chief executive officer of Bio-Techne Corporation (TECH).
Where is Bio-Techne Corporation headquartered?
Bio-Techne Corporation is headquartered in United States.
Does TECH pay a dividend?
Yes — Bio-Techne Corporation (TECH) paid a trailing twelve-month dividend of USD 0.32 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did TECH go public?
Bio-Techne Corporation (TECH) completed its initial public offering in 1989.